Table 1.
Demographic and clinical characteristics: means and standard deviations by group and assessment time.
| Baseline (T1) | Follow-up (T2) | |||
|---|---|---|---|---|
| Variable | HFA (n = 34) | TD (n = 45) | HFA (n = 34) | TD (n = 45) |
| Sex (male/female) | 28/6 | 29/16 | 28/6 | 29/16 |
| Age | 11.6 (2.0) | 11.4 (1.5) | 13.8 (2.0) | 13.5 (1.4) |
| Time since T1 (mts) | – | – | 25.6 (3.5) | 24.9 (1.2) |
| Mother's education (yrs) | 13.1 (2.6) | 14.7 (2.4) | – | – |
| FSIQa | 99.9 (17.4) | 104.5 (13.1) | 98.5 (16.9) | 106.5 (12.7) |
| CBCL total T-scoreb | 63.8 (9.2) | 38.2 (8.6) | 55.9 (11.0) | 36.3 (8.3) |
| ASSQ raw scorec | 20.6 (8.4) | 1.7 (1.9) | 20.4 (8.9) | 1.2 (2.9) |
| ARS-IV inattention raw scored | 12.7 (6.1) | 1.5 (1.8) | 9.9 (5.7) | 1.6 (2.0) |
| VIQe | 98.6 (17.9) | 99.4 (12.1) | 97.5 (18.0) | 102.6 (13.5) |
HFA, High-functioning Autism: TD, typically developing children.
a
FSIQ, full scale IQ. IQ estimated measures from the Wechsler Abbreviated Scale of Intelligence (WASI).
b
CBCL, Child Behavior Checklist, total problems scale.
c
ASSQ, Autism spectrum screening questionnaire.
d
ARS-IV, ADHD Rating Scale version IV.
e
VIQ, estimated verbal intelligence.